Rethinking Idiopathic Pulmonary Fibrosis — oldham 2021

Idiopathic pulmonary fibrosis (IPF) causes both patients and their loved ones great suffering. Understanding of IPF has advanced greatly since the first attempts to describe this illness in the 1960s. An era of higher confidence diagnoses with less intrusive procedures and more successful treatments has been ushered in as a result of this progress, which has consistently challenged previous diagnostic and treatment paradigms. This review describes how, over the past 50 years, clinical practice and research have changed how we think about IPF. Here, the development of IPF pathogenesis knowledge is presented along with diagnostic testing and therapy options.

Oldham JM, Vancheri C. Rethinking Idiopathic Pulmonary Fibrosis. Clin Chest Med. 2021 Jun;42(2):263-273. doi: 10.1016/j.ccm.2021.03.005. PMID: 34024402; PMCID: PMC9075032.